Pacritinib 100 mg C78837 Pill - gray & red capsule/oblong, 22mm
Generic Name: pacritinib
Pill with imprint Pacritinib 100 mg C78837 is Gray & Red, Capsule/Oblong and has been identified as Vonjo 100 mg. It is supplied by CTI BioPharma Corp.
Vonjo is used in the treatment of Myelofibrosis and belongs to the drug class multikinase inhibitors. Vonjo 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pacritinib 100 mg C78837
Vonjo
- Generic Name
- pacritinib
- Imprint
- Pacritinib 100 mg C78837
- Strength
- 100 mg
- Color
- Gray & Red
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- CTI BioPharma Corp.
- National Drug Code (NDC)
- 72482-0100
See also:
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Ojjaara
Ojjaara (momelotinib) may be used to treat adults with certain types of myelofibrosis (MF) who have ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Inrebic
Inrebic is used to treat certain types of myelofibrosis (MF) in adults. It is an oral capsule taken ...
Fedratinib
Fedratinib is used for certain types of myelofibrosis (MF) in adults, relieving night sweats ...
Momelotinib
Momelotinib (brand name Ojjaara) may be used to treat adults with certain types of myelofibrosis ...
Ruxolitinib
Ruxolitinib (oral) is used to treat certain types of myelofibrosis (MF), polycythemia vera (PV) ...
More about Vonjo (pacritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.